EMAIL: [email protected]
PHONE: 720.643.4450

Kristen Nichols

Kristen is a Denver-based reporter for Marijuana Business Daily specializing in the hemp and CBD industries. Previously, she worked at the Associated Press for nearly 20 years. She started covering the marijuana legalization movement in 2009 – when medical stores started popping up around Denver – and wrote about the state’s first legal hemp harvest. Kristen also covered agriculture and politics in Maryland and her home state of Georgia.


Kentucky notches fiber first in testing hemp for bridge repair

A Kentucky bridge is the first in the nation to be repaired with hemp fibers, part of a University of Kentucky project to strengthen the state’s aging bridges. Engineering professor Issam Harik led the project, part of a larger effort to study the use of fiber-reinforced polymer composites in bridge repair and building construction. Harik used hemp […]

Read More

Exclusive webcast: Live Q&A on USDA’s new hemp rules

The new national hemp rules from the U.S. Department of Agriculture (USDA) are out, and they could bring big changes for your hemp business. Hemp Industry Daily Editor Kristen Nichols sits down Tuesday to field questions live about the upcoming changes to the USDA hemp rules. Topics will include: THC testing procedures. What to expect […]

Read More

Activists resolve to fine-tune stalled NY hemp and CBD bill

Industry insiders in New York are regrouping to salvage a hemp extract bill that’s been languishing on Gov. Andrew Cuomo’s desk since it was passed last summer. Cuomo is expected to issue a “friendly veto” of the bill, which will enable it to be reintroduced during the budget process next year, said Jonathan Miller, a […]

Read More

Charlotte’s Web blames lack of FDA direction for slow revenue growth

CBD giant Charlotte’s Web said slow action by federal health regulators is causing disappointing growth in mass-market retail channels. The Boulder, Colorado, company told investors Wednesday that “a lack of regulatory direction” from the U.S. Food and Drug Administration (FDA) is slowing growth in food, drug and mass (FDM) sales channels. “Full revenue growth potential […]

Read More

Exclusive Webcast: Breaking down the USDA’s hemp rules

After decades of prohibition, hemp is now an agricultural commodity like any other, regulated by the U.S. Department of Agriculture (USDA). But there’s a lot to unpack in the USDA’s new hemp rules. In an exclusive webcast, Hemp Industry Daily editor Kristen Nichols sits down with Vicente Sederberg hemp attorney Shawn Hauser to discuss: What […]

Read More

CBD company plans aromatherapy, cosmetics focus in new partnership

A Canadian supplements company that makes CBD extracts plans to focus on aromatherapy topicals through a collaboration with a prominent flavorings and scents firm. Neptune Wellness Solutions of Laval, Quebec, which makes fish-oil supplements and cannabinoid oils, said Monday it is giving $24 million worth of stock warrants to International Flavors & Fragrances (IFF) in […]

Read More

Lawsuits, delays and an explosion: Troubles mount for Kentucky hemp pioneer GenCanna

A Kentucky hemp company that helped pioneer large-scale CBD production methods and takes some credit for getting the hemp plant legalized is now facing a cascade of business challenges. First, delays piled up at GenCanna’s rural Kentucky processing facility that the company envisions making a processing hub for several Midwestern states. Then, farmers in GenCanna’s […]

Read More

Losses narrow for GW Pharmaceuticals on dramatic revenue increase

A strong uptick in doctor prescriptions and coverage from health insurers is being credited for solid quarterly revenues for GW Pharmaceuticals. The London-based firm that makes cannabis-derived CBD medicines reported revenue of $91 million for the third quarter ended Sept. 30, up more than 3,500% from the same period a year ago. Despite the revenue […]

Read More

CV Sciences reports falling revenues, sales amid ‘flood’ of new competitors

CV Sciences, a San Diego-based CBD manufacturer, reported revenue of $12.6 million for the third quarter ended Sept. 30, down more than 7% from the same period a year ago. Profit for the quarter was $8.4 million, down 15% from the previous year. The results fell well short of analyst expectations even as CV Sciences […]

Read More